New Scholar in Aging Award - Application Procedures

The objective of The Ellison Medical Foundation New Scholar in Aging program is to support new investigators of outstanding promise in the basic biological sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide new faculty with support during the especially critical first three years of their independent research career.

New Scholar Applications are solicited by invitation only. Invitations to nominate candidates for the 2013 application cycle will be sent to the president and to the head of the sponsored research program for invited institutions in October, 2012. The invited institutions may nominate two candidates to apply. For invited institutions: Please notify The Ellison Medical Foundation if your institution has a new contact for the nomination process so that the initial letter of invitation will be received by the appropriate individual.
To discuss institutional eligibility, contact Dr. Kevin Lee.

Areas of interest include, but are not limited to:

  • Structural biology
  • Molecular genetics
  • Studies with model systems ranging from lower eukaryotes to humans
  • Inquiries testing the relevance of simpler models to human aging
  • Genetic epidemiology of aging
  • Candidate longevity genes
  • Aging in the immune system
  • Host defense molecules in aging systems
  • Mechanisms of free radical induced cell aging
  • Mechanisms of aging in various differentiated cell populations
  • Gene/environment and gene/gene interactions
  • Integrative physiology
  • New approaches to age-modulated disease mechanisms


New Scholar awards are for up to $100,000 per year, total costs, for a four year period.

The following file may be downloaded and used as a guide to prepare your application. Instructions for the 2013 New Scholar Application

You must complete your New Scholar Application ONLINE at:

Beginning in December, 2012 nominated candidates will receive an email providing instructions and a password to access the application website.


Applications are due by February 28, 2013 (online submissions must be completed by 11:59 p.m. Eastern Standard Time).

Reference letters must be received separately by the same deadline and should be sent by direct mail or email to:
The Ellison Medical Foundation
104 E. Ridgeville Blvd.
Mount Airy, MD 21771
FAX: 301-829-6413

The letter must indicate the applicant's name and identify the reference's relationship to the applicant (for example, “Thesis Advisor”, “Scientific Reference”).


New Scholar awardees will be notified in June, 2013.

The earliest possible start date of the award is dependent on completion of the award agreement with the grantee institution.


These awards are intended for investigators who are in the first three (3) years of their research careers following their post-doctoral fellowship experience. For the 2013 competition, nominees must hold regular full time appointments (tenure or non-tenure) on the faculty of the sponsoring institution by March 1, 2013; and they must have been in such an appointment, whether at the sponsoring institution or other institution(s), for no more than three years as of July 15, 2013, i.e. the first appointment having been made no earlier than July 15, 2010. Time spent in clinical internships, post-doctoral training, residencies, or in work toward board certification does not count as part of the three-year limit.

The Ellison Medical Foundation New Scholars may hold one other career development award from a private source concurrently for up to one year. This limitation is with regard to overlap of funding type, even in the absence of scientific overlap. Examples of conflicting career development or new faculty awards include, but are not limited to:
American Cancer Society - Research Scholar; American Diabetes Association - Career Development Award or Junior Faculty Award; American Federation for Aging Research - AFAR Research Grant; Arnold & Mary Beckman Foundation - Young Investigator Award; Brookdale Foundation - Brookdale Fellowship; Burroughs Wellcome Fund - Career Awards Medical Scientist; Dana Foundation - Brain & Immuno-Imaging (Conventional or Cellular) Award; Hartford Foundation/Amer. Geriatric Society - Jahnigen Career Development Scholar or T.F. Williams Research Scholar; Hillblom Foundation - Hillblom Start-up Grant; Edward Mallinckrodt Jr. Foundation - Research Grant; March of Dimes - Basil O'Connor Starter Scholar Research Award; Pew Charitable Trust - PEW Scholar Award; Rosalind & Arthur Gilbert Foundation/AFAR - New Investigators Award in Alzheimer's disease; Sidney Kimmel Foundation for Cancer Research - Kimmel Scholar Award; and Whitehall Foundation - Grants-in-Aid. New Scholar Awards will only be made for the full four-year term. If a conflicting award is accepted prior to the New Scholar Award, this must be resolved by either declining The Ellison Medical Foundation award or arranging to terminate the conflicting award within one year.


Nominees for the New Scholar Award are expected to have great promise as potential leaders of biomedical science with relevance to aging. Each nominee's potential for scientific innovation, leadership, and relevance to aging will be evaluated by the Aging New Scholar Review Group and the Scientific Advisory Board, based upon the nominee's research proposal, scientific contributions to date, and the reference statements provided by those who know the nominee and his/her work well. The quality and relevance of the nominee's publications and the importance to aging of the nominee's proposed research will be significant factors in the evaluation process. Depending upon the number of nominations submitted and the qualifications of the nominees, up to 25 New Scholars will be selected in 2013.

Terms of the Award

Each award will be made for up to $100,000 per year, total costs, for a four year period. Funding for years two, three, and four is contingent upon submission of an acceptable progress report.

Acceptable uses for award funds include project-related: salaries, other personnel costs, equipment, supplies, resource acquisition and travel. The scholar's salary costs (including fringe benefits) may not exceed $20,000 per year. Carry-overs in excess of $25,000 must be approved by the Foundation. Not more than 8% of the total award may be deducted for overhead costs.

For all (new and non-competing renewal) awards supporting research involving human subjects, animal subjects, research collaborations with foreign institutions, biosafety issues, or human embryonic stem cells the Foundation will require the following documentation before an award can be made:

  1. Human subjects:
    1. Copies of the protocol submitted to the Institutional Review Board(s) for this project* and the notification of protocol approval from all relevant IRBs (for funded awards, an annual update will be required at the time of the progress report).
    2. Documentation from the applicant institution that the principal investigator has completed training on the protection of human research participants.
  2. Animal subjects:
    1. A copy of Institutional Animal Care and Use Committee approval for this project* (for funded awards, an annual update will be required at the time of the progress report).
  3. Foreign component:
    1. A letter of support from the collaborating in-country institution, signed by an appropriate official of that institution.
  4. Biosafety: Research supported by The Ellison Medical Foundation is expected to conform to the relevant NIH Guidelines for biosafety, including those for handling of hazardous reagents and those for research involving recombinant DNA and gene transfer. (see:
    1. A copy of Institutional Biosafety Committee approval for this project*.
  5. Human Embryonic Stem Cell Research Committee approval of the protocol for this project* if it involves human embryonic stem cells.

*Approval for this project means the EMF-funded project, not a similar protocol funded by another entity.

Address any questions to:

Kevin Lee, Ph.D.
Executive Director
Phone: 301-829-6410